Related Experiment Video

Updated: Apr 7, 2026

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.8K

Hepatitis C associated to substance abuse: ever closer to a treatment without Interferon

Roberto Muga1, Paola Zuluaga, Arantza Sanvisens

  • 1Servei de Medicina Interna. Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona.. rmuga.germanstrias@gencat.cat.

Adicciones
|July 2, 2015
PubMed

Insights

Hepatitis C virus (HCV) infection is a global health issue. New Direct Antiviral Agents (DAA) offer effective, safer treatments, potentially eliminating the need for Interferon in future hepatitis C regimens.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Public Health

Background:

  • Hepatitis C virus (HCV) infection is a significant global public health concern, leading to liver disease worldwide.
  • Injection drug use is linked to a majority of new HCV infections in Western countries.
  • Current HCV treatment standards require review due to emerging therapies.

Purpose of the Study:

  • To review current standards of care for hepatitis C virus infection.
  • To discuss the impact of new Direct Antiviral Agents (DAA) on HCV treatment.
  • To highlight the need for inclusive treatment policies for individuals with substance use disorders.

Main Methods:

  • Review of current literature on hepatitis C virus (HCV) infection and its treatment.
  • Analysis of the role and efficacy of Direct Antiviral Agents (DAA).
  • Examination of World Health Organization (WHO) treatment guidelines.

Main Results:

  • Direct Antiviral Agents (DAA) are effective, safer, and better-tolerated treatments for HCV infection.
  • DAA are used in combination therapies, and Interferon may become unnecessary.
  • The 2014 WHO guidelines incorporate some DAA therapies.

Conclusions:

  • The advent of DAA necessitates a re-evaluation of HCV treatment standards.
  • Future HCV treatment regimens are expected to rely on DAA, potentially excluding Interferon.
  • Proactive and inclusive treatment policies are crucial for managing HCV in populations with substance use disorders.

More Related Videos

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

7.5K
A Protocol for Analyzing Hepatitis C Virus Replication13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.8K

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
46
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.5K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
897
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.7K
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
32
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
186